Translator Disclaimer
Presentation
6 March 2020 Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease (Conference Presentation)
Author Affiliations +
Proceedings Volume 11241, Biophotonics and Immune Responses XV; 1124103 (2020) https://doi.org/10.1117/12.2541561
Event: SPIE BiOS, 2020, San Francisco, California, United States
Abstract
Transcranical photobiomodulation (tPBM, 1267 nm, 32 J/cm2) is effective non-invasive method for clearance of beta-amyloid from the brain in mice with Alzheimer’s disease and for improvemen of their neurological status.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Oxana V. Semyachkina-Glushkovskaya, Ekaterina Zinchenko, Maria Klimova, Andrey Terskov, Arkady Abdurashitov, Alexander Dubrovsky, Inna Blokhina, Alexander Khorovodov, Ilana Agranovich, Nikita Navolokin, Alexander Shirokov, Elena Saranceva, Aysel Mamedova, Valery Tuchin, and Juergen Kurths "Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: breakthrough strategies for non-pharmacologic therapy of Alzheimer’s disease (Conference Presentation)", Proc. SPIE 11241, Biophotonics and Immune Responses XV, 1124103 (6 March 2020); https://doi.org/10.1117/12.2541561
PROCEEDINGS
PRESENTATION


SHARE
Advertisement
Advertisement
Back to Top